A Novel Nomogram Predicting the Overall Survival of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Large Population-Based Investigation | SpringerLink
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
MP47-11 DIFFERENTIAL ASSOCIATION OF BODY MASS INDEX ON SURVIVAL OUTCOMES IN RENAL CELL CARCINOMA: IMPACT OF TUMOR HISTOLOGY | Journal of Urology
Oncology Data Advisor - Final Overall Survival Results of the CLEAR Study in Renal Cell Carcinoma
Artificial intelligence prediction model for overall survival of clear cell renal cell carcinoma based on a 21-gene molecular prognostic score system - Figure f1 | Aging
Cancers | Free Full-Text | Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Overall survival vs immunohistochemistry. The Kaplan Meier graph... | Download Scientific Diagram
Figure 1 | Clear Cell Cancer of the Uterine Corpus: The Association of Clinicopathologic Parameters and Treatment on Disease Progression
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
CLEAR Study: First-Line Lenvatinib Plus Pembrolizumab Maintains Advantage Over Sunitinib in Advanced RCC at Long-Term Follow-up
ASCO 2023: Final Prespecified Overall Survival Analysis of CLEAR: 4-Year Follow-up of Lenvatinib + Pembrolizumab vs Sunitinib in Patients with Advanced RCC
Analysis of the Overall survival for IQGAP3 in human cancers. (A) The... | Download Scientific Diagram
Oncotarget: Identification intermediate-risk | EurekAlert!
Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis
Frontline Therapy in Advanced Clear Cell RCC: The CLEAR Trial
Loss-of-function mutations in PPP2R1A Correlate with Exceptional Survival in Ovarian Clear Cell Carcinomas Treated with Immune Checkpoint Inhibitors (099) - ScienceDirect
Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma | Anticancer Research
ASCO 2022: Progression-Free Survival After Second Line of Therapy (PFS-2) for Metastatic Clear Cell RCC in Patients Treated With First-Line Immunotherapy Combinations
Progression-free survival and overall survival for patients with clear... | Download Scientific Diagram
Kaplan–Meier estimates the (A) cancer-specific and (B) overall survival... | Download Scientific Diagram
Cancers | Free Full-Text | COL7A1 Expression Improves Prognosis Prediction for Patients with Clear Cell Renal Cell Carcinoma Atop of Stage
Non-Small Cell Lung Cancer
Prognostic Value of Serum CA9 in Patients with Metastatic Clear Cell Renal Cell Carcinoma under Targeted Therapy | Anticancer Research
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging | British Journal of Cancer
Six RNA binding proteins (RBPs) related prognostic model predicts overall survival for clear cell renal cell carcinoma and is associated with immune infiltration | Biomolecules and Biomedicine
